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I N T H I S I S S U E
Lipopolysaccharide, ADAR2 and Hirschsprung's disease Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies New biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy Captopril mitigates splenomegaly and myelofibrosis in the Gata1 low murine model of myelofibrosis
Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway Signalling through Src family kinase isoforms is not redundant in models of thrombo-inflammatory vascular disease HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo Toll-like receptor 9 and the pathogenesis of erosive autoimmune arthritis Distinct roles for Iĸβ kinases alpha and beta in regulating pulmonary endothelial angiogenic function during late lung development
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